Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60).
作者信息
Kim Bo-Yeon, Choi Dug-Hyun, Jung Chan-Hee, Mok Ji-Oh, Kang Sung Koo, Kim Chul-Hee
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
出版信息
J Obes Metab Syndr. 2018 Jun 30;27(2):128-129. doi: 10.7570/jomes.2018.27.2.128.
Abstract
摘要
相似文献
1
Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60).2型糖尿病患者中维生素D状态与非酒精性脂肪性肝病及腹部脂肪堆积的关系（《肥胖与代谢综合征杂志》2018年；第27卷：53 - 60页）
J Obes Metab Syndr. 2018 Jun 30;27(2):128-129. doi: 10.7570/jomes.2018.27.2.128.
2
Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53-60).2型糖尿病患者中维生素D状态与非酒精性脂肪性肝病及腹部脂肪堆积的关系（《肥胖与代谢综合征杂志》2018年；27:53 - 60）
J Obes Metab Syndr. 2018 Jun 30;27(2):125-127. doi: 10.7570/jomes.2018.27.2.125.
3
Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38).信件：肌肉减少症与非酒精性脂肪性肝病的存在及严重程度显著相关（《肥胖与代谢综合征杂志》2019年；28:129 - 138）
J Obes Metab Syndr. 2020 Mar 30;29(1):76-77. doi: 10.7570/jomes19068.
4
Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38).反应：肌肉减少症与非酒精性脂肪性肝病的存在及严重程度显著相关（《肥胖与代谢综合征杂志》2019年；28:129 - 38）。
J Obes Metab Syndr. 2020 Mar 30;29(1):78-80. doi: 10.7570/jomes20009.
5
Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38).信函：肌肉减少症与非酒精性脂肪性肝病的存在及严重程度显著相关（《肥胖与代谢综合征杂志》2019年；28:129 - 38）
J Obes Metab Syndr. 2020 Jun 30;29(2):158-159. doi: 10.7570/jomes20018.
6
Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38).反应：肌肉减少症与非酒精性脂肪性肝病的存在及严重程度显著相关（《肥胖与代谢综合征杂志》2019年；28:129 - 38）。
J Obes Metab Syndr. 2020 Jun 30;29(2):160-162. doi: 10.7570/jomes20046.
7
Addendum to: Anti-obesity Effects of Extract in Zucker Fatty Rats and High-Fat Diet Sprague Dawley Rats through Upregulation of Uncoupling Protein 1 (J Obes Metab Syndr 2021;30:32-43).增编：提取物通过上调解偶联蛋白1对 Zucker 肥胖大鼠和高脂饮食 Sprague Dawley 大鼠的抗肥胖作用（《肥胖与代谢综合征杂志》2021年；30:32 - 43）
J Obes Metab Syndr. 2022 Mar 30;31(1):92-93. doi: 10.7570/jomes22017.
8
Letter: The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity (J Obes Metab Syndr 2019;28:46-52).信函：根据肥胖的有无探讨肌肉力量与糖尿病之间的差异关联（《肥胖与代谢综合征杂志》2019年；28:46 - 52）
J Obes Metab Syndr. 2019 Dec;28(4):295-296. doi: 10.7570/jomes.2019.28.4.295. Epub 2019 Dec 30.
9
Response: The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity (J Obes Metab Syndr 2019;28:46-52).回应：根据肥胖与否探讨肌肉力量与糖尿病之间的差异关联（《肥胖与代谢综合征杂志》2019年；28:46 - 52）
J Obes Metab Syndr. 2019 Dec;28(4):297-298. doi: 10.7570/jomes.2019.28.4.297. Epub 2019 Dec 30.
10
Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21).回应：达格列净治疗6个月对无动脉粥样硬化性心血管疾病的肥胖2型糖尿病患者代谢谱和内皮细胞功能障碍的影响（《肥胖与代谢综合征杂志》2020年；29:215 - 21）
J Obes Metab Syndr. 2021 Mar 30;30(1):74-75. doi: 10.7570/jomes21006.
本文引用的文献
1
Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes.2型糖尿病患者中维生素D状态与非酒精性脂肪性肝病及腹部脂肪堆积的关系
J Obes Metab Syndr. 2018 Mar 30;27(1):53-60. doi: 10.7570/jomes.2018.27.1.53.
2
Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease?: a Cross-Sectional Study of the Healthy Population.维生素D是非酒精性脂肪性肝病的独立危险因素吗？：一项健康人群的横断面研究。
J Korean Med Sci. 2017 Jan;32(1):95-101. doi: 10.3346/jkms.2017.32.1.95.
3
Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark.德国东北部和丹麦的肥胖测量与维生素D浓度
Nutr Metab (Lond). 2015 Jun 10;12:24. doi: 10.1186/s12986-015-0019-0. eCollection 2015.
4
Vitamin D insufficiency is associated with abdominal obesity in urban Asian Indians without diabetes in North India.在印度北部无糖尿病的城市亚洲印度人中，维生素D不足与腹部肥胖有关。
Diabetes Technol Ther. 2014 Jun;16(6):392-7. doi: 10.1089/dia.2013.0303. Epub 2014 Feb 14.
5
Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?维生素 D 与非酒精性脂肪性肝病（NAFLD）：这不仅仅是一种关联吗？
Hepatology. 2013 Sep;58(3):1166-74. doi: 10.1002/hep.26390. Epub 2013 Jul 29.
6
Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity.容量稀释而非隔离，更好地解释了肥胖人群维生素 D 水平低的原因。
Obesity (Silver Spring). 2012 Jul;20(7):1444-8. doi: 10.1038/oby.2011.404. Epub 2012 Jan 19.
7
Association of plasma vitamin D levels with adiposity in Hispanic and African Americans.西班牙裔和非裔美国人血浆维生素D水平与肥胖的关联
J Clin Endocrinol Metab. 2009 Sep;94(9):3306-13. doi: 10.1210/jc.2009-0079. Epub 2009 Jun 23.
8
Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease.胰岛素抵抗、代谢综合征与非酒精性脂肪性肝病。
J Clin Endocrinol Metab. 2005 Mar;90(3):1578-82. doi: 10.1210/jc.2004-1024. Epub 2004 Dec 14.
Zotero 插件